DexCom (DXCM) Misses Q4 EPS by 1c, Offers FY Guidance
Get Alerts DXCM Hot Sheet
Price: $130.71 -2.67%
EPS Growth %: +58.8%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +58.8%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.91, $0.01 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $568.9 million versus the consensus estimate of $554.7 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.21-2.31 billion.
- Non-GAAP Gross profit margin of approximately 65%
- Non-GAAP Operating margin of approximately 13%
- Adjusted EBITDA margin of approximately 23%
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!